Clinical Trials in Denver

Showing 11041-11060 of 15,604 trials

Evaluation of WIRION™ EPS in Lower Extremities Arteries

NCT02780349

Demonstrate the safety and performance of the WIRION™ EPS in subjects undergoing lower extremity atherectomy for the treatment of Peripheral Arterial Disease (PAD)

Peripheral Arterial Disease (PAD)

Gardia Medical103 participantsStarted May 2016

Denver, Colorado, United States • Davenport, Iowa, United States • New Orleans, Louisiana, United States +7 more locations

COMPLETEDPhase 1/2< 1 mile

A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

NCT01217957

The purpose of Phase 1 of this study was to determine the safety, tolerability, maximum tolerated dose (MTD), and recommended Phase 2 dose (RP2D) of oral ixazomib administered in combination with lenalidomide and low-dose dexamethasone in participants with newly diagnosed multiple myeloma (NDMM). The purpose of Phase 2 of this study was to determine the overall response rate (ORR) and further evaluate the tolerability and toxicity of the combination of oral ixazomib, lenalidomide, and low-dose dexamethasone in patients with NDMM.

Multiple Myeloma

Millennium Pharmaceuticals, Inc.65 participantsStarted Nov 2010

Scottsdale, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +13 more locations

Evaluation of WIRION™ EPS in Lower Extremities Arteries

A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Find Trials by Condition in Denver

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease

Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine

Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)

Home Testing of Day and Night Closed Loop With Pump Suspend Feature

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)

A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1

A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

The Spot Sign for Predicting and Treating ICH Growth Study

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

PF-06372865 in Subjects With Photosensitive Epilepsy

TRIGEN SURESHOT™ Distal Targeting System Study

BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL

Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment

Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer